Effect of Vedrin Combined with Meglumine Adenosine Cyclophosphate in Treatment of Congestive Heart Failure

Objective To explore clinical effect of Vedrin combined with meglumine adenosine cyclophosphate in patients with congestive heart failure.Methods 56 patients with congestive heart failure were randomly divided into treatment group(n=27) and control group(n=29).The control group was treated with routine therapy including oxygen inhalation,diuretic,digitalis,vasodilator,angiotensin-converting enzyme inhibitor(ACEI),antibiotic therapy,and supporting treatment.The treatment group was treated with Vedrin 1.5g+5% glucose 250ml intravenously drip,once a day for 2 weeks,meglumine adenosine cyclophosphate 120mg+5% glucose 250ml intravenously drip,once a day for 2 weeks,as well as routine therapy.After two weeks,the clinical effects compared between two groups.Results The heart function and cardiac indexes were improved after treatment in both two groups(P0.01),the difference was significant between treatment group and control group after treatment(P0.05).Conclusion Vedrin combined with meglumine adenosine cyclophosphate in treating of congestive heart failure is effective and safe.